Helin-Tanninen M, Naaranlahti T, Kontra K, Savolainen K
Pharmacy Department, Kuopio University Hospital, Kuopio, Finland.
J Clin Pharm Ther. 2007 Feb;32(1):49-55. doi: 10.1111/j.1365-2710.2007.00798.x.
To compare content uniformities between different sizes of extemporaneously compounded nifedipine oral powders and capsules, in order to find out if capsules could be used instead of oral powders as paediatric medications.
Actual content and content uniformity of extemporaneously compounded 1-mg nifedipine oral powders and capsules were evaluated by a high performance liquid chromatographic assay. Capsules and powders were prepared by triturating 10-mg nifedipine tablets with different amounts of lactose or microcrystalline cellulose with a mortar and pestle using a standard geometric dilution technique. Oral powders were weighed individually and capsules were filled by a hand-operated capsule-filling machine. Four different sizes of powders (500, 300, 100 and 50 mg) and three different sizes of capsules (numbers 1, 3 and 4) were prepared. Ten oral powders and 10 capsules from each batch were randomly selected and individually assayed for nifedipine amount.
The extemporaneously prepared nifedipine oral powders and capsules were within acceptable limits for content uniformity, as defined by the European Pharmacopoeia, but the results indicate that the loss of nifedipine during the preparation process may be considerable for both preparations. The concentration on nifedipine decreased while the total mass of the oral powder decreased. These results demonstrate that nifedipine oral powders can be replaced by capsules, whose contents are emptied for use, in paediatric medications. Compounding small capsules, such as size number 3 or 4, is acceptable when considering the average drug content. The total weight of the oral powder should be at least 300 mg.
The preparation of nifedipine in all studied capsule sizes was safe with either lactose monohydrate or microcrystalline cellulose as excipients. Thus, emptied capsules seem to be a good choice for delivering a paediatric medication. The loss of nifedipine was considerable in oral powders with low total weight.
比较不同规格的硝苯地平临时配制口服粉末与胶囊的含量均匀度,以确定胶囊是否可替代口服粉末用于儿科用药。
采用高效液相色谱法测定临时配制的1毫克硝苯地平口服粉末与胶囊的实际含量及含量均匀度。通过使用标准几何稀释技术,用研钵和研杵将10毫克硝苯地平片与不同量的乳糖或微晶纤维素研磨来制备胶囊和粉末。分别称取口服粉末,并用手动胶囊填充机填充胶囊。制备了四种不同规格的粉末(500、300、100和50毫克)和三种不同规格的胶囊(1号、3号和4号)。从每批中随机选取10份口服粉末和10粒胶囊,分别测定硝苯地平含量。
临时配制的硝苯地平口服粉末与胶囊的含量均匀度在欧洲药典规定的可接受范围内,但结果表明两种制剂在制备过程中硝苯地平的损失可能相当大。口服粉末中硝苯地平的浓度随着口服粉末总质量的减少而降低。这些结果表明,在儿科用药中,硝苯地平口服粉末可用内容物可倒出使用的胶囊替代。考虑到平均药物含量,配制小号胶囊(如3号或4号)是可以接受的。口服粉末的总重量应至少为300毫克。
以一水乳糖或微晶纤维素为辅料,所有研究规格的胶囊中硝苯地平的制备都是安全的。因此,空胶囊似乎是递送儿科药物的一个好选择。总重量低的口服粉末中硝苯地平的损失相当大。